Effects of Lower Limb Resistance Band Exercises in Phase 1 Cardiac Rehabilitation

NCT ID: NCT06319651

Last Updated: 2024-07-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

56 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-03-01

Study Completion Date

2024-06-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will be randomized controlled trial with non-probability purposive sampling. Study conducted among post CABG patients. Sample size will be 56, 28 in each group. Outcome will be measured by using 6 minute walk test, Spirometry (FVC, FEV1/FVC and PEF), Functional Independence Measure.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study will be randomized controlled trial with non-probability purposive sampling. Study conducted among post CABG patients. Descriptive analysis will be applied. Data will be collected from Rehmatul lil Alameen Institute of cardiology Lahore. Sample size will be 56, 28 in each group. In addition to the routine Phase 1 cardiac rehabilitation for experimental group the exercise protocol consisted of 10 minutes of warm up, elastic band strength exercise protocol (30 minutes) and cool down (5 minutes) so that an exercise session lasted about 45-50 minutes, exercise will performed circularly 2 sets, 10 repetition with a 2 minute rest after each cycle and monitored the performance of exercise for 6 days. Resisted band exercise are Extending thighs, Closing thighs, Opening thighs, Bending thighs, Dorsiflexion, Plantarflexion. For control group routine Phase 1 cardiac rehabilitation only. Outcome will be measured by using 6 minute walk test, Spirometry (FVC, FEV1/FVC and PEF), Functional Independence Measure.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cardiovascular Diseases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Randomized controlled trial (RCT). Pre \& Post data collection
Primary Study Purpose

OTHER

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Experimental Group

In addition to the routine Phase 1 cardiac rehabilitation, Resistance Exercises

* Extending thighs
* Closing thighs
* Opening thighs
* Bending thighs
* Bending ankles
* Ankle opening

Group Type EXPERIMENTAL

Lower Limb Resistance Band Exercises

Intervention Type OTHER

* Extending thighs
* Closing thighs
* Opening thighs
* Bending thighs
* Bending ankles
* Ankle opening

Routine Phase 1 cardiac rehabilitation

Intervention Type OTHER

Routine Phase 1 cardiac rehabilitation only.

Routine Phase 1 cardiac rehabilitation

Routine Phase 1 cardiac rehabilitation only.

Group Type ACTIVE_COMPARATOR

Routine Phase 1 cardiac rehabilitation

Intervention Type OTHER

Routine Phase 1 cardiac rehabilitation only.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Lower Limb Resistance Band Exercises

* Extending thighs
* Closing thighs
* Opening thighs
* Bending thighs
* Bending ankles
* Ankle opening

Intervention Type OTHER

Routine Phase 1 cardiac rehabilitation

Routine Phase 1 cardiac rehabilitation only.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 35 to 60
* Female and Male both
* Hemodynamic stable patients
* Arrhythmias or angina not present
* Post elective sternotomy surgery
* Post extubating

Exclusion Criteria

* Chronic obstructive pulmonary disease
* Neurological Sequelae
* Neuromuscular disease
* Emergency or off pump surgery
* Surgical re-intervention
* Patient who remained on mechanical ventilation longer than 24 hours
* Patient who had a baseline partial pressure of oxygen (PaO2) less than 75 mmHg and partial pressure of carbon dioxide (PCO2) 45 mmHg
* Patients who had history of respiratory tract infection within a period of three months
Minimum Eligible Age

35 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Riphah International University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Muhammad Faizan Hamid, Ms-CPPT

Role: PRINCIPAL_INVESTIGATOR

Riphah International University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Rehmatul lil Alameen Institute of cardiology

Lahore, Punjab Province, Pakistan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Pakistan

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

REC/RCR&AHS/23/0360

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.